Closing in on a Mesothelioma Cure?

It seems the drug, ONCONASE, is showing some promising results in increasing the longevity of mesothelioma patients. With trials going on in the US and Europe, now the Aussies have granted the drug "orphan drug status", which encourages health care providers to use the drug and gives it priority over other treatments.

According to this press release, mesothelioma is becoming more common down under so this is good news for the maker of this drug. Of course, since Australia only banned the use of asbestos a couple years ago, it probably isn't that surprising that they have an increasing rate of mesothelioma.

Of course, this doesn't mean there's a "cure" yet. But the longer you live, the better your chances they'll find a cure. And that sure beats being dead...unless you happen to be in a "persistent vegatative state" in the state of Florida.